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Abstract
Background: The widespread incorporation of behavioral support interventions into exercise trials has sometimes
caused confusion concerning the primary purpose of a trial. The purpose of the present paper is to offer some
conceptual and methodological distinctions among three types of exercise trials with a view towards improving
their design, conduct, reporting, and interpretation.
Discussion: Exercise trials can be divided into “health outcome trials” or “behavior change trials” based on their
primary outcome. Health outcome trials can be further divided into efficacy and effectiveness trials based on their
potential for dissemination into practice. Exercise efficacy trials may achieve high levels of exercise adherence by
supervising the exercise over a short intervention period ("traditional” exercise efficacy trials) or by the adoption of
an extensive behavioral support intervention designed to accommodate unsupervised exercise and/or an extended
intervention period ("contemporary” exercise efficacy trials). Exercise effectiveness trials may emanate from the
desire to test exercise interventions with proven efficacy ("traditional” exercise effectiveness trials) or the desire to
test behavioral support interventions with proven feasibility ("contemporary” exercise effectiveness trials). Efficacy,
effectiveness, and behavior change trials often differ in terms of their primary and secondary outcomes, theoretical
models adopted, selection of participants, nature of the exercise and comparison interventions, nature of the
behavioral support intervention, sample size calculation, and interpretation of trial results.
Summary: Exercise researchers are encouraged to clarify the primary purpose of their trial to facilitate its design,
conduct, and interpretation.
Randomized controlled trials (RCTs) are a common
design for testing many health interventions including
exercise. In recent years, exercise RCTs have become
more complex and challenging because of a greater
focus on methodological rigor and the desire to test
longer exercise interventions, unsupervised exercise
interventions, and higher volume exercise interventions.
These changes have necessitated a greater focus on
exercise adherence in these trials and have stimulated
the incorporation of behavioral support interventions
into many exercise trials for which behavior change was
not the primary purpose. Behavioral support interven-
tions consist of strategies to improve exercise adherence
such as incentives, print materials, telephone counsel-
ling, group sessions, websites, and other behavior modi-
fication techniques. The incorporation of behavioral
support interventions into exercise RCTs has been a
major methodological advance in exercise research,
however, it has sometimes caused confusion concerning
the primary purpose of a trial. Was the trial designed to
improve a health outcome or to understand exercise
behavior change? Was the trial designed to demonstrate
efficacy or effectiveness? This confusion may lead to
improperly designed trials and/or the misinterpretation
of trial results. The purpose of the present paper is to
offer some conceptual and methodological distinctions
among different types of exercise trials with a view
towards improving their design, conduct, reporting, and
interpretation.
Health Outcome Trials Versus Behavior
Change Trials
In simplest terms, exercise RCTs can be divided into
“health outcome trials” or “behavior change trials”
(Figure 1). Health outcome trials are those trials in
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an exercise intervention on some health outcome such
as cardiorespiratory fitness, body composition, psychoso-
cial functioning, biomarkers, or disease states. Behavior
change trials, on the other hand, are those trials in
which the primary purpose is to examine the effects of a
behavioral support intervention on some aspect of exer-
cise behavior itself such as the type, volume, intensity,
or maintenance of exercise. In the past, these two types
of exercise trials largely led separate lives and were
viewed as independent but related steps towards
improving health through exercise. In recent years, how-
ever, several major changes in the exercise field have
brought these two types of trials together.
The Rise of Behavioral Support Interventions in
Health Outcome Trials
Several key changes have occurred in the exercise field
over the past two decades that have prompted the inclu-
sion of behavioral support interventions into many
health outcome trials: (a) the adoption of the Consoli-
dated Standards of Reporting Trials (CONSORT) [1],
(b) longer exercise intervention trials, (c) unsupervised
exercise intervention trials, and (d) higher volume exer-
cise intervention trials. Prior to the CONSORT guide-
lines [1], exercise health outcome trials rarely
incorporated behavioral support interventions into their
methodology, probably because of the exclusively super-
vised exercise protocols, the relatively short exercise
interventions (e.g., 12-24 weeks), and methodological
practices that were accepted at the time. In pre-
CONSORT exercise health outcome trials, participants
who did not adhere to the exercise intervention were
often removed from the analyses and/or not reported in
the trial. The solution to nonadherence in these trials
was to recruit more participants until the desired sample
size of “adherers” was achieved. The acceptability of this
practice was brought into question with the adoption of
the CONSORT guidelines [1] by most medical, health,
and behavioral journals, including one of the leading
exercise science journals, Medicine & Science in Sports
&E x e r c i s e . Among its many recommendations for
improving the quality of RCTs, the CONSORT guide-
lines stated that all trial participants must be analyzed
according to their assigned condition regardless of their
level of adherence to the trial protocol. Consequently,
nonadherence became a potentially important issue even
in health outcome trials with supervised exercise proto-
cols and shorter length interventions.
At the same time, researchers began conducting
longer exercise interventions (e.g., 1-2 years) to deter-
mine the sustained effects of exercise over time and
also to examine more distal effects of exercise such as
disease endpoints. The expansion of health outcome
trials to one year, two years, and even longer provided
further impetus for the inclusion of behavioral support
interventions as it was obvious that sustained exercise
adherence would be a challenge even with motivated
participants and supervised exercise protocols. More-
over, other researchers began testing unsupervised exer-
cise interventions with the goal of improving the
potential for translation of exercise research into prac-
tice. In these trials, it was also clear that adherence to
unsupervised exercise would require some level of beha-
vioral support, even for shorter length interventions.
Finally, researchers became interested in testing higher
volumes of exercise that were hypothesized to be neces-
sary for addressing some of the more intractable health
outcomes (e.g., obesity, disease endpoints). Again, it was
clear that the testing of these higher exercise volumes
(e.g., 150-300 minutes per week) would require signifi-
cant behavioral support. These four factors-adoption of
the CONSORT guidelines [1], longer exercise interven-
tions, unsupervised exercise interventions, and higher
volume exercise interventions-prompted the incorpora-
tion of behavioral support interventions into many
health outcome trials for which behavior change was
not the primary purpose.
Figure 1 Schematic representation of three types of exercise trials.
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(Pragmatic) Trials
Complicating the matter further is the growing impor-
tance of the distinction between efficacy and effective-
ness trials [2]. Efficacy trials (also called explanatory
trials) determine whether an intervention produces the
intended effect under ideal circumstances whereas effec-
tiveness trials (also called pragmatic trials) determine
whether an intervention produces the intended effect
under “real-world” conditions [3]. Most RCTs, including
exercise, contain a mix of efficacy and effectiveness ele-
ments [4]. In this sense, efficacy and effectiveness trials
exist along a continuum and their designation is a
matter of degree. Moreover, there are many individual
features of an RCT and each can vary along the effi-
cacy-effectiveness continuum; not just the overall RCT
[2,5-8]. One of the key differences between efficacy and
effectiveness trials from this paper’s perspective is the
anticipated level of adherence to the intervention.
Reflecting this key issue, efficacy refers to whether an
intervention works in people who receive it (i.e., who
adhered to the protocol) whereas effectiveness refers to
whether an intervention works in people to whom it has
been offered (i.e., it assumes at least some level of non-
adherence) [4]. The incorporation of behavioral support
interventions into many exercise health outcome trials
has further clouded the complex distinction between
efficacy and effectiveness trials in exercise research.
Traditional and Contemporary Efficacy Trials in
Exercise Research
In exercise research, a distinction might be made
between “traditional” exercise efficacy trials and “con-
temporary” exercise efficacy trials. In traditional exercise
efficacy trials, exercise adherence was typically assured
by a completely supervised exercise intervention testing
ar e l a t i v e l ym o d e s te x e r c i s ev o l u m e( e . g . ,3d a y sp e r
week for 30 minutes) over a relatively short intervention
(e.g., 12-24 weeks). In one sense, the supervised exercise
itself was the “behavioral support intervention” that
ensured the high level of exercise adherence over the
short intervention period (i.e., optimal conditions). As
such, there was relatively little need to incorporate any
modern behavioral support techniques into traditional
exercise efficacy trials. As noted earlier, the adoption of
the CONSORT guidelines [1] may make behavioral sup-
port interventions potentially important even for these
traditional exercise efficacy trials.
Contemporary exercise efficacy trials, on the other
hand, typically include one or more of the following fea-
tures: (a) an unsupervised or partially supervised exer-
cise intervention, (b) an extended exercise intervention
(e.g., 1-2+ years), and/or (c) a relatively large volume of
exercise (e.g., 150-300 minutes of exercise per week).
The nature of these trials makes it unlikely that they are
able achieve a high level of adherence sufficient to test
the efficacy of the exercise intervention without includ-
ing some level of behavioral support. In contemporary
exercise efficacy trials, the goal of the behavioral support
intervention is to obtain a high level of exercise adher-
ence over an extended period of time so that the pri-
mary question concerning the particular health outcome
can be answered. The behavioral support intervention,
in essence, is viewed as the primary mechanism for
ensuring a high level exercise adherence in the absence
of completely supervised exercise over a short interven-
tion period. The level of behavioral support needed in
contemporary exercise efficacy trials likely varies by the
degree of exercise supervision, the length of the exercise
intervention, and the volume of the exercise interven-
tion (Figure 2).
Traditional and Contemporary Effectiveness Trials
in Exercise Research
Exercise efficacy trials and effectiveness trials are both
health outcome trials with the primary purpose of deter-
m i n i n gt h ee f f e c t so fa ne x e r c i s ei n t e r v e n t i o no na
health outcome. Contemporary exercise efficacy trials
and effectiveness trials also both include modern beha-
vioral support interventions to help answer the primary
health outcome question. Consequently, the distinguish-
ing feature between contemporary exercise efficacy trials
and effectiveness trials appears to be the nature of the
behavioral support intervention. In contemporary exer-
cise efficacy trials, researchers typically develop or adopt
a behavioral support intervention that is intensive
enough to achieve a high level of adherence to the exer-
cise intervention over an extended period of time so
that the primary health outcome question can be
answered. Efficacy trials, by definition, are less con-
cerned about whether the behavioral support interven-
tion is feasible in practice. Conversely, an exercise
effectiveness trial typically adopts a behavioral support
intervention that is consistent with practice or at least
deemed potentially feasible to put into practice. The
goal is then to determine whether the exercise interven-
tion achieved by a feasible behavioral support interven-
tion is sufficient for improving some important health
outcome.
There also appears to be two approaches to effective-
ness trials in exercise research. The “traditional”
approach to an effectiveness trial is usually one that pro-
ceeds from a successful efficacy trial demonstrating the
benefits of an exercise intervention under optimal con-
ditions. The purpose of the traditional effectiveness trial
is then to determine if the benefits of the exercise inter-
vention are still evident under “real-world” conditions (i.
e., in practice). The “contemporary” approach to an
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proceeds from a successful behavior change trial
demonstrating that a feasible behavioral support inter-
vention is able to increase exercise behavior to a poten-
tially meaningful level. The purpose of the
contemporary effectiveness trial is then to determine if
the exercise intervention achieved by the feasible beha-
vioral support intervention is sufficient for improving
some health outcome in practice.
Efficacy, Effectiveness, and Behavior Change
Trials in Exercise Research
As noted earlier, the widespread adoption of behavioral
support interventions into many exercise RCTs has
sometimes caused confusion concerning the primary
intent of the trial. At the simplest level, it is sometimes
unclear if the intent was to conduct a health outcome
trial with behavioral support or a behavior change trial
with secondary health outcomes. At a more complex
level, it is sometimes unclear if the intent was to con-
duct an efficacy trial but an inadequate level of beha-
vioral support resulted in modest adherence and gave
the impression of an effectiveness trial. In other cases, it
is unclear if the intent was to conduct an effectiveness
trial but an inadequate level of behavioral support
resulted in no improvements in health outcomes and
gave the impression of a behavior change trial. Still, in
other cases, it is unclear if the intent was to conduct a
behavior change trial but improvements in some health
outcomes gave the impression of an effectiveness trial.
In the following sections, some potentially distinguishing
features among efficacy, effectiveness, and behavior
change trials are discussed under the headings of selec-
tion of primary and secondary outcomes, adoption of
theoretical models, selection of participants, nature of
the exercise intervention, nature of the behavioral sup-
port intervention, nature of the comparison interven-
tion, sample size calculation and analysis, and
interpretation of trial results (Table 1).
Selection of Primary and Secondary Outcomes
Perhaps the most obvious and important distinction
between health outcome trials and behavior change
trials is the identificationo ft h ep r i m a r yo u t c o m e .I n
efficacy and effectiveness trials, the primary outcome is
a health outcome (e.g., aerobic fitness, biomarkers, qual-
ity of life, disease outcomes). In behavior change trials,
the primary outcome is an aspect of exercise behavior
(e.g., type, dose, attendance, number of steps). Although
this distinction may appear simple and straight forward,
confusion can arise in exercise trials when both behavior
and health variables are identified as outcomes, and
especially when both are identified as primary outcomes.
Behavior change does not appear to be an appropriate
primary or secondary outcome in efficacy or effective-
ness trials because outcomes in an RCT are defined as
events that are present after the participants receive the
intervention [4]. Given that exercise is the actual inter-
vention in a health outcome trial, adherence to the
intervention itself cannot be an outcome of the inter-
vention. Failure to exercise in a health outcome trial is
not a negative effect on a primary or secondary out-
come, it is a protocol deviation. The fact that the exer-
cise may be unsupervised does not make it an outcome
in an efficacy or effectiveness trial.
Conversely, it does seem acceptable, and even meritor-
ious, to identify health outcomes as secondary outcomes
in behavior change trials because these are potential
outcomes that may follow from the behavioral support
intervention and the ensuing exercise behavior change.
If improved, these health outcomes may indicate a parti-
cularly meaningful level of behavior change. In this con-
text, the goal is to determine whether the exercise
behavior that results from such a behavioral support
intervention is sufficient for improving some important
health outcome. For the same reasons as above, how-
ever, it does not seem appropriate to identify adherence
to the behavioral support intervention (e.g., telephone
calls completed, attendance at group sessions, visits to
the website) as a primary or secondary outcome in a
behavior change trial. Failure to complete the behavioral
support intervention in a behavior change trial is a pro-
tocol deviation.
Adoption of Theoretical Models
Another important distinction among efficacy, effective-
ness, and behavior change trials is the nature of the the-
o r i e st h a ti n f o r mt h er e s e a r c h .I ns i m p l e s tt e r m s ,t h e r e
are two types of theories or models: theories that
explain the outcomes of a behavior and theories that
explain the determinants of ab e h a v i o r( s e eF i g u r e1 ) .
Outcome theories attempt to explain how the exercise
intervention (e.g., type, dose, intensity, frequency)
improves a health outcome. These theories or models
often include biological or physiological variables but
might also include health-related fitness or psychosocial
variables depending on the nature of the health out-
come. Behavioral theories, on the other hand, attempt
to explain how a behavioral support intervention (e.g.,
goal setting, physician recommendation, telephone
counselling) might improve exercise behavior. These
theories often focus on social cognitive variables such as
attitude, self-efficacy, and social support but might also
include a wider range of variables such as physiological
and environmental factors.
In efficacy trials, researchers should select an outcome
theory that will explain how the exercise intervention is
thought to change the health outcome. Traditional
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would not normally need to adopt a behavioral theory.
Contemporary efficacy trials, however, would likely ben-
efit from following a behavioral theory because of the
substantial behavioral support intervention that is often
included and the greater risk of nonadherence. In effec-
tiveness trials, it would seem that researchers should
adopt both an outcome theory to guide the exercise
intervention and a behavioral theory to guide the beha-
vioral support intervention. In behavior change trials,
researchers typically need only to adopt a behavioral
theory. Confusion can arise in exercise trials when there
is a “mismatch” between the type of theory and the
reported outcomes. That is, exercise trials should not
cite behavioral theories to claim they are “theory-based”
when reporting health outcomes and, conversely, they
should not cite outcome theories to claim they are “the-
ory-based” if they report on the determinants of exercise
adherence.
Selection of Participants
The selection of participants may also vary across effi-
cacy, effectiveness, and behavior change trials. In effi-
cacy trials, participants are typically selected based on
their motivation and ability to complete and respond
to the particular intervention [6,8]. In exercise efficacy
trials, this usually means selecting participants not cur-
rently performing the particular exercise intervention
yet capable of performing the exercise intervention. In
effectiveness trials, participants are only moderately
selected based on their motivation and ability because
o ft h ed e s i r et or e f l e c t“real-world” conditions that
broaden eligibility criteria [6,8]. In exercise effective-
ness trials, this may mean including participants cur-
rently performing some or even all of the intended
exercise intervention if this reflects the target group in
clinical or public health practice. In behavior change
trials, participants may have various levels of motiva-
tion and ability depending on the focus of the trial.
Because the goal is not to improve a health outcome
per se, a behavior change trial might target people
with no interest in exercise, some interest in exercise,
or a strong interest in exercise. Moreover, it
may include participants currently performing no exer-
cise, some exercise, or already meeting the exercise
prescription with the goal of maintaining exercise
behavior. Given the differences in participant selection,
the generalizability of findings is usually lower in effi-
cacy trials and higher in effectiveness and behavior
change trials [6].
Figure 2 Level of behavioral support needed for exercise efficacy trials based on the degree of exercise supervision and length of the
exercise intervention.
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Efficacy Trial
Traditional Contemporary Effectiveness Trial Behavior Change Trial
Primary Outcome: A health outcome A health outcome A health outcome An exercise behavior
outcome
Secondary Outcomes: Other health outcomes Other health outcomes Other health outcomes Other behavior/health
outcomes
Protocol Deviations: Not exercising Not exercising/behavioral
support
Not exercising/behavioral
support
Not completing behavioral
support
Theoretical Model: Outcome model needed Outcome model needed Outcome model needed Outcome model not needed
Behavior model not
needed
Behavior model beneficial Behavior model needed Behavior model needed
Participants: Highly selected Highly selected Moderately selected Variably selected
Not exercising/limited
exercise
Not exercising/limited
exercise
Exercise levels reflective of
practice
Variable exercise levels
Lower generalizability Lower generalizability Higher generalizability Higher generalizability
Exercise Intervention: Completely supervised Completely/partially
supervised
Unsupervised/partially
supervised
NA (exercise is the outcome)
Precise exercise type/
volume
Partially flexible types/
volumes
Flexible exercise types/volumes Flexible exercise types/
volumes
Agree to exercise Agree to exercise Agree to exercise Asked to exercise
No/limited behavioral
support
Agree to behavioral
support
Agree to behavioral support Agree to behavioral support
Behavioral Support
Intervention:
Minimal/informal Extensive/comprehensive Moderate/feasible for
dissemination
Varied but systematic and
feasible
Comparison Intervention: No exercise intervention Minimal exercise
intervention
Standard of care At least exercise
recommendation
Agree not to exercise Allowed to exercise Allowed to exercise Asked to exercise
No behavioral support No/limited behavioral
support
Behavioral support as per
standard care
Behavior support based on
purpose
Sample Size: Powered for health
outcome
Powered for health
outcome
Powered for health outcome Powered for behavioral
outcome
No allowance for
nonadherence
Allowance for
nonadherence
Allowance for nonadherence No allowance for
nonadherence
Analysis: Intention-to-treat Intention-to-treat Intention-to-treat Intention-to-treat
Prespecified subgroup
analyses
Prespecified subgroup
analyses
Prespecified subgroup analyses Prespecified subgroup
analyses
Interpretation of Results:
Positive trial Improves primary health
outcome
Improves primary health
outcome
Improves primary health
outcome
Improve primary behavior
outcome
Adequate exercise
adherence
Adequate exercise
adherence
Adequate exercise adherence Adequate support adherence
Support adherence not
required
Support adherence not
required
Negative trial No change in health
outcome
No change in health
outcome
No change in health outcome No change in behavioral
outcome
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ally be asked to agree to the trial protocol prior to ran-
domization. In traditional efficacy trials, the trial
protocol includes supervised exercise. In contemporary
efficacy and effectiveness trials, the trial protocol might
include supervised and unsupervised exercise as well as
the behavioral support intervention. Consequently, parti-
cipants in health outcome trials should be asked to
a g r e et od o( o rt r yt od o )t h ee x e r c i s ei n t e r v e n t i o na s
well as the behavioral support intervention as a method
of supporting their exercise adherence. In behavior
change trials, the trial protocol includes the behavioral
support intervention but not the exercise itself because
that is the outcome. Consequently, intervention partici-
pants in a behavior change trial should be asked to
agree to follow the behavioral support intervention but
not to agree to do the exercise because that is the pri-
mary outcome of the trial.
Nature of the Exercise Intervention
The nature of the exercise intervention may also vary
among exercise trials [8]. In efficacy trials, there is often
a precise exercise intervention for participants to follow
that includes the type, frequency, intensity, duration,
and progression of exercise. For example, participants
may be asked to exercise on a cycle ergometer three
times per week for 30 minutes at 70-85% of their maxi-
mum capacity. Typically, there is limited flexibility in
how participants achieve the exercise intervention. In
effectiveness trials, there is often a general exercise
intervention for participants to follow (e.g., a desired
volume) and there may be considerable flexibility in
how participants are allowed to achieve the exercise
intervention. For example, participants may be asked to
exercise for 10 metabolic equivalent task (MET) hours
per week but be allowed to choose any type, frequency,
intensity, or duration of exercise that meets this general
prescription. Alternatively, participants may receive pre-
specified ranges of exercise from which to chose (e.g.,
several types of aerobic exercise, moderate-to-vigorous
exercise, 3-5 days/week, 20-60 minutes in duration).
Moreover, effectiveness trials often establish only a
minimum exercise goal, not a maximum goal (e.g., parti-
cipants may be asked to perform at least 150 minutes of
exercise/week but be allowed to exceed this goal). In
behavior change trials, there is no exercise intervention
per se because exercise is the outcome. Nevertheless,
there is often an exercise behavioral goal that partici-
pants are asked to achieve as part of the behavioral sup-
port intervention.
Nature of the Behavioral Support Intervention
Another major distinction among exercise trials is the
nature of the behavior support intervention. As noted
earlier, in traditional exercise efficacy trials, there is typi-
cally no formalized behavioral support intervention.
Exercise adherence is usually achieved by highly select
participants, the shorter length of the intervention, and
the supervised exercise that likely entails at least some
positive social support and accountability. In contem-
porary efficacy trials involving unsupervised exercise or
an extended intervention, the behavioral support
Table 1 Summary of some distinguishing features among efficacy, effectiveness, and behavior change exercise trials
(Continued)
Adequate exercise
adherence
Adequate exercise
adherence
Adequate exercise adherence Adequate support adherence
Support adherence not
required
Support adherence not
required
Inconclusive trial No change in health
outcome
No change in health
outcome
No change in health outcome No change in behavioral
outcome
Inadequate exercise
adherence
Inadequate exercise
adherence
Inadequate exercise adherence Inadequate support
adherence
Nature of the Result:
Definitive Negative trial Negative trial Positive trial Negative trial
No effect in practice is
likely
No effect in practice is
likely
Effect in practice is likely No effect in practice is likely
Ambiguous Positive trial Positive trial Negative trial Positive trial
Effect in practice is
unknown
Effect in practice is
unknown
Effect under better conditions
unknown
Effect on health outcomes
unknown
(unless shown in trial or
literature)
Courneya International Journal of Behavioral Nutrition and Physical Activity 2010, 7:81
http://www.ijbnpa.org/content/7/1/81
Page 7 of 12intervention is usually sophisticated and comprehensive,
b u ti ti st y p i c a l l ya“kitchen sink” approach. That is,
contemporary efficacy trials usually incorporate as many
behavioral support techniques and motivational strate-
gies as necessary because behavior change is a means to
an end and not an end in itself. The goal of these trials
is to determine if a particular exercise intervention
improves an important health outcome under optimal
conditions, not to systematically disentangle what com-
ponents of the behavioral support intervention might be
helpful or to be concerned about the feasibility of the
intervention. In efficacy trials, close monitoring of exer-
cise adherence and behavioral support adherence is
required during the trial to ensure corrective action is
taken if adherence falters [8].
In effectiveness trials, the behavioral support interven-
tion is usually one that reflects practice or at least has
the potential for being translated into practice. Similar
to efficacy trials, however, the goal of effectiveness trials
is to determine if a particular exercise intervention
improves some health outcome, not to systematically
disentangle what components of the behavioral support
intervention worked. Any monitoring and corrective
action for exercise adherence and/or behavioral support
adherence in effectiveness trials should be consistent
with the intended practice context [8]. Conversely, in
behavior change trials, the behavioral support interven-
t i o nm a yb es i m p l eo rs o p h i s t i c a t e dd e p e n d i n go nt h e
question; however, the focus is on systematically evalu-
ating the individual or packaged behavioral support
intervention to determine its effects on exercise beha-
vior. There is no ongoing monitoring of exercise beha-
vior in behavior change trials because exercise behavior
is the primary outcome. Monitoring and corrective
action for the behavioral support intervention may be
considered depending on the nature of the trial.
Nature of the Comparison Intervention
The comparison intervention also differs among effi-
cacy, effectiveness, and behavior change trials. In tradi-
tional efficacy trials, participants in the comparison
group are often asked not to exercise or not to increase
their exercise from baseline and to agree to these
instructions prior to randomization. These instructions
are optimal for efficacy trials because contamination in
the comparison group is as problematic as nonadher-
ence in the intervention group. In efficacy trials, the
goal is to determine if the exercise intervention
improves a health outcome under optimal conditions.
The optimal condition includes 100% adherence in the
intervention group and 0% contamination in the com-
parison group. Asking comparison participants not to
exercise is often accepted by research ethics boards
depending on the purpose of the study, the length of
the intervention, and the risk to participants of not
exercising.
The comparison group intervention in contemporary
efficacy trials and effectiveness trials is much more com-
plex for methodological and ethical reasons. Asking
comparison participants not to exercise or not to
increase their exercise may not be considered ethical if
it is for an extended period of time or if the population
is considered at-risk. It may not be scientifically justifi-
able in effectiveness trials where the goal is to replicate
“real-world” environments where comparison partici-
pants are free to exercise if they want. This complexity
has led to a great deal of variability in what comparison
participants are asked to do in contemporary efficacy
and effectiveness trials. In some trials, comparison parti-
cipants are not asked anything but are given standard
health materials that often include information on exer-
cise (e.g., public health exercise guidelines). In other
trials, they are explicitly recommended to exercise but
are not provided with any of the behavioral support
intervention or only a limited version of the intervention
(e.g., printed materials only, one behavioral support ses-
sion, a few telephone calls). Still, in other trials, they are
given a more extensive health intervention that may be
important for general health or for their specific disease
condition but it may or may not include exercise. The
lack of clear exercise instructions to the comparison
group in contemporary efficacy trials is probably an
attempt to balance the ethical concern of having com-
parison participants not exercise, with the scientific con-
cern of maximizing differences in exercise behavior
between the intervention and comparison groups.
In effectiveness trials, participants should receive the
current standard of care for exercise if one already exists
in the particular practice setting [8]. If not, the lack of
clear exercise instructions to comparison participants is
probably the correct approach ethically and scientifically
because the goal is to determine the effects of exercise
in a “real world” setting in which comparison partici-
pants are allowed to exercise on their own but may not
receive any support.
In behavior change trials, the comparison group inter-
vention has also varied. It does not seem scientifically
justifiable, however, to ask comparison participants in a
behavior change trial not to exercise or not to increase
their exercise; or even not to provide them with any
instructions. The utility of a behavioral support inter-
vention that is superior to a comparison group that was
asked not to exercise or that was not provided with any
instructions to exercise seems dubious. Consequently,
except in cases where the recommendation itself is the
behavior support intervention under investigation (e.g.,
physician recommendation, oncologist recommenda-
tion), it would seem that comparison groups in behavior
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the same level of exercise as the intervention group.
Any additional behavioral support provided to the com-
parison group in a behavior change trial (including any
contact control) would depend on the nature and pur-
pose of the trial and what the researchers wanted to be
able to say about the intervention.
Sample Size Calculation and Analysis
In traditional efficacy trials, the trial is powered for the
primary health outcome and, given that nonadherence
or contamination are not anticipated, they are typically
not factored into the power calculation. Allowance may
be made for loss-to-follow-up, but this is a different
issue. In contemporary efficacy and effectiveness trials,
the trial is also powered for the primary health outcome,
however, an ap r i o r iallowance for some prespecified
level of nonadherence and contamination may be fac-
tored into the power calculation. In behavior change
trials, the trial should be powered for the primary beha-
vioral outcome and typically no allowance is made for
any nonadherence or contamination with the behavioral
support intervention. The primary analysis in all trials
should follow the intention-to-treat principle [1]. Any
secondary analysis that deviate from intention-to-treat
should be prespecified [1].
Interpretation of Trial Results
Accurate interpretation of trial results is important but
not always provided [9]. In an efficacy trial, failure to
improve the primary health outcome in the face of ade-
quate exercise adherence (however defined) is inter-
preted as a negative trial (i.e., the exercise intervention
does not work for that health outcome). Improvements
in important secondary health outcomes may be note-
worthy but do not change the overall interpretation of
the trial. Poor exercise adherence in an efficacy trial is a
major protocol deviation. Failure to improve the primary
health outcome in the face of inadequate exercise adher-
ence in an efficacy trial results in an inconclusive trial.
An inconclusive trial is one in which the primary ques-
tion could not be answered because of some substantial
methodological problem such as poor protocol adher-
ence. Researchers conducting efficacy trials should resist
the temptation of interpreting an inconclusive efficacy
trial as a negative effectiveness trial or a positive beha-
vior change trial.
In an effectiveness trial, interpretation of the results
is the same as for an efficacy trial. In addition, poor
adherence to the behavioral support intervention in an
effectiveness trial or contemporary efficacy trial is also
a protocol deviation. Nevertheless, even if poor adher-
ence to the behavioral support intervention was the
likely cause of the poor exercise adherence, it is the
lack of exercise adherence that renders the trial incon-
clusive, not the poor adherence to the behavioral sup-
port intervention. Researchers conducting
contemporary efficacy trials or effectiveness trials
should resist the temptation of interpreting a negative
or inconclusive health outcome trial as a positive beha-
vior change trial.
I nab e h a v i o rc h a n g et r i a l ,f ailure to improve the pri-
mary behavioral outcome in the face of adequate adher-
ence to the behavioral support intervention (however
defined) is interpreted as a negative trial (i.e., the beha-
vioral support intervention does not work). Even if sec-
ondary health outcomes improve, the trial would still be
considered negative as these outcomes are unlikely to be
attributable to the exercise behavior change itself
(assuming accurate measurement of exercise) and, in
any case, were not the primary outcome [9]. Conversely,
a positive change in the primary behavioral outcome is
interpreted as a positive trial even if secondary health
outcomes do not improve. Certainly, improvements in
secondary health outcomes would further substantiate
the importance of the behavior change achieved in the
trial, but they were not the primary focus. In a behavior
change trial, failure to improve the primary behavioral
outcome in the face of inadequate adherence to the
behavioral support intervention is a major protocol
deviation that results in an inconclusive trial. Research-
ers conducting behavior change trials should resist the
temptation of interpreting a positive, negative, or incon-
clusive behavior change trial that improved secondary
health outcomes as a positive effectiveness trial.
The types of exercise RCTs also vary in regard to the
nature of the definitive result that each trial produces
(Figure 3) [7]. For efficacy trials, the definitive result is a
negative trial. In that case, it is certain that the exercise
intervention has no effect on the health outcome. A
positive efficacy trial is an ambiguous finding because it
is unknown if the health outcome can be achieved in
practice. The converse is true for effectiveness trials [7].
A positive effectiveness trial is the definitive result
because the trial demonstrates that the health outcome
can be improved under “real-world” conditions although
additional steps toward dissemination may be required
[2]. A negative effectiveness trial may be ambiguous
because it is unclear if a positive effect on the health
outcome could have been achieved under more favor-
able conditions [7]. Finally, a negative behavior change
trial is a definitive result because it is clear that the
behavioral support intervention would not improve any
health outcomes in practice. A positive behavior change
trial may be ambiguous because it is unclear if it will
actually improve health outcomes in practice (unless
important secondary health outcomes were also
improved in the trial or there is compelling evidence of
Courneya International Journal of Behavioral Nutrition and Physical Activity 2010, 7:81
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studies).
Discussion
The purpose of this paper was to offer some conceptual
and methodological distinctions between health out-
come trials (efficacy and effectiveness) and behavior
change trials. It was argued that these trials differ in
terms of many important attributes and design issues.
Several issues raised in this paper warrant further
discussion.
One important issue is whether it is possible to con-
duct both a behavior change trial and a health outcome
trial as part of the same trial. The difficulty with this
approach is that it requires multiple primary outcomes,
which is not recommended by CONSORT [1]. Multiple
primary outcomes may lead to internally inconsistent
decisions because the selection of a primary outcome
drives all other methodological decisions in the trial
[1,7,8]. For example, an exercise RCT may select exer-
cise behavior, weight loss, and depression as its primary
outcomes. In this trial, would the eligibility criteria
include only nonexercisers who are obese and
depressed? Or would it allow current exercisers who are
obese and depressed, or obese people who are not
depressed and depressed people who are not obese?
What exercise intervention would be selected? Perhaps
a very high volume of exercise might be best for weight
loss but not for depression. Perhaps yoga would be
great for depression but not for weight loss. What about
the selection of gold standard measures given limited
resources? Should the researchers spend significant
money on the gold standard measures of exercise beha-
vior (e.g., direct observation, accelerometers) or obesity
(e.g., DEXA scans, CT scans) or depression (e.g., clinical
interviews)? Will the sample size be determined by
expected changes in exercise, obesity, or depression?
What will the comparison group receive? Should the
comparison group be asked not to exercise? How will
the intervention be interpreted? Will it be successful if
people exercise but are still obese and depressed? Is it
successful if they lose weight but are still depressed, or
are less depressed but still obese? Trial design issues are
often difficult to resolve when there are competing pri-
mary outcomes.
It seems reasonable for a behavior change trial to have
a secondary purpose of documenting changes in health
outcomes but the trial would still have been conceptua-
lized and designed as a behavior change trial with all
the important trial decisions based on this purpose. It
Figure 3 Nature of the trial result produced by three types of exercise trials.
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come trial to have a secondary purpose of testing a
behavior support intervention because the former is
actually contingent on the latter. That is, the health out-
come trial is unable to answer its primary question if
behavior change does not occur (i.e., it becomes an
inconclusive trial). If behavior change is uncertain in a
health outcome trial, it seems the best approach would
be to conduct a feasibility study demonstrating that
behavior change is highly likely before moving to the
health outcome trial.
Another interesting issue is whether it is possible to
make the same conceptual distinction between efficacy
and effectiveness for behavior change trials as it is for
health outcome trials. In the present paper, behavior
change trials have been largely conceptualized as effec-
tiveness trials by default. Perhaps it would have been
more prudent to develop a 2 × 2 typology of trial out-
come (behavior change versus health outcome) by trial
attitude (efficacy versus effectiveness). In considering
this option, it does not seem helpful to conduct efficacy-
oriented behavior change trials because the primary pur-
pose of such trials is usually to translate health outcome
research into practice. Moreover, it does not seem to
make sense for behavior change trials to only select
highly motivated participants or to use a behavioral sup-
port intervention that is not feasible for practice when
the goal is to disseminate the exercise research to as
many people as possible in the target population. It
would seem that the only reason for incorporating a
behavioral support intervention that is not feasible in
practice is because the goal of the trial is to establish
the efficacy of the health intervention. Having said that,
the utility of distinguishing between efficacy and effec-
tiveness behavior change trials may warrant further
discussion.
It is also critical to note that what is feasible to be
put into practice varies dramatically from context to
context [7,8]. For example, supervised exercise proto-
cols delivered by highly qualified personnel may indeed
be readily transferable into practice in certain clinical
settings with dedicated space, sophisticated equipment,
and highly qualified personnel (e.g., cardiac rehabilita-
tion unit). Similarly, supervised exercise protocols may
even be feasible to deliver in many community-based
settings such as public and private fitness and recrea-
tional centers that possess the necessary equipment
and qualified staff. Conversely, supervised exercise pro-
tocols may not be readily transferable into practice in
rural communities or in public health settings because
of the lack of facilities, personnel, and limited funding.
T h ek e yp o i n ti st h a tw h a ti sc o n s i d e r e df e a s i b l et ob e
translated into exercise practice varies with the prac-
tice setting. Consequently, exercise researchers
conducting effectiveness trials should make explicit the
intended practice setting for their intervention and
design their trial accordingly [8].
Another important issue is the order of conducting
the different types of exercise RCTs. As noted earlier, it
is generally argued that efficacy trials should precede
effectiveness trials [4]. That is, once the efficacy of an
intervention is proven, then it needs to be tested for its
effectiveness. In exercise research, efficacy trials followed
by an attempt to put the positive results into practice
without the demonstration of effectiveness may fail in
settings that cannot deliver supervised exercise interven-
tions or provide extensive behavioral support interven-
tions (e.g., rural, public health). One might reasonably
argue that, in practice settings where supervised exercise
or extensive behavioral support interventions are not
likely feasible, it may be more productive to begin with
contemporary effectiveness trials that test exercise inter-
ventions that are feasible even though they may not
have proven efficacy. Thus, in exercise research, effec-
tiveness trials might also emanate from positive behavior
change trials with proven feasibility in a given practice
setting.
This paper provides a first attempt to highlight some
conceptual and methodological issues that have arisen
with the incorporation of modern behavioral support
interventions into many exercise trials. It was a difficult
paper to write because of the complexity of this topic
and the diversity of exercise research. There are signifi-
cant limitations in this paper. One limitation is that the
paper does not attempt to integrate the distinction
between health outcome trials and behavior change
trials into other existing research typologies beyond the
common efficacy-effectiveness distinction (e.g., Phase I-
IV trials, translational trials, dissemination trials, com-
parative effectiveness trials, research phases, etc.). A sec-
ond limitation is that every exercise trial is unique and
some of the general observations made in this paper
may not apply to individual exercise trials. A third lim-
itation is that there does not appear to be a clear dis-
tinction between efficacy and effectiveness trials because
it is the individual elements of a trial that vary along the
efficacy-effectiveness continuum and researchers might
intentionally, and appropriately, mix efficacy and effec-
tiveness attributes [8]. Another limitation is that the
paper does not address research designs beyond the tra-
ditional RCT. Finally, it is unclear if the issues raised in
this paper apply to other health behavior interventions
(e.g., nutrition) or to interventions that target multiple
health behaviors.
In summary, exercise RCTs are growing in sophistica-
tion and complexity because of the desire to test longer
exercise interventions, unsupervised exercise interven-
tions, and higher volume exercise interventions. These
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support interventions into many exercise RCTs and has
sometimes confused the primary purpose of the trial.
Researchers conducting exercise RCTs are encouraged
to consider the nature of their trial in terms of its health
outcome versus behavior change focus and its position
on the efficacy versus effectiveness continuum. Clarity
in the goals of the trial may improve the trial methods
and result in better quality trials more likely to inform
clinical, community, and public health exercise
interventions.
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